Relapse and Acquired Rifampin Resistance in HIV-Infected Patients with Tuberculosis Treated with Rifampin- or Rifabutin-Based Regimens in New York City, 1997-2000

This publication has 21 references indexed in Scilit:

• Recurrent Tuberculosis in the United States and Canada
  American Journal of Respiratory and Critical Care Medicine, 2004
• Rifampin‐Monoresistant Tuberculosis in New York City, 1993–1994
  Clinical Infectious Diseases, 1997
• Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis
  New England Journal of Medicine, 1996
• Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
  American Journal of Respiratory and Critical Care Medicine, 1995
• A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis: A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis
  Tubercle and Lung Disease, 1995
• Rifampicin-resistant Mycobacterium tuberculosis
  The Lancet, 1995
• Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicin
  Tubercle and Lung Disease, 1994
• SHORT-COURSE CHEMOTHERAPY IN PULMONARY TUBERCULOSIS: A Controlled Trial by the British Thoracic and Tuberculosis Association
  The Lancet, 1975